Metagenomi, Inc. Common Stock (MGX) — Cash Flow Reinvestment Rate
Metagenomi, Inc. Common Stock (MGX) has a Cash Flow Reinvestment Rate of 0.63x as of December 2022, reinvesting $42.38 Million (capex $3.51 Million plus investments $-38.87 Million) from operating cash flow of $67.73 Million. Explore cash efficiency ratio of Metagenomi, Inc. Common Stock to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Metagenomi, Inc. Common Stock Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for Metagenomi, Inc. Common Stock across 2 annual periods. Explore Metagenomi, Inc. Common Stock strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year capital reinvestment analysis for Metagenomi, Inc. Common Stock. For live market cap and broader valuation context, see how much is Metagenomi, Inc. Common Stock worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 4.58x | $136.18 Million | $29.72 Million | $13.98 Million | ▲ +43.9% |
| 2021 | 3.18x | $77.22 Million | $24.26 Million | $2.90 Million | — |